 | • レポートコード：MRC2312MG10066 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の腫瘍NGS検出市場規模と予測を収録しています。・世界の腫瘍NGS検出市場：売上、2018年-2023年、2024年-2029年 ・世界の腫瘍NGS検出市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の腫瘍NGS検出市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医療機器」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 腫瘍NGS検出のグローバル主要企業は、Agilent、 Thermo Fisher Scientific、 BGI Group、 Roche Foundation Medicine、 Sinopharm Group、 Fosunpharma、 Novogene、 Geneseeq、 AmoyDx、 Burning Rock Medicine、 Perkin Elmer、 Qiagen NV、 Partek、 Illumina Inc.、 Pacific Biosciences of California Inc.、 Life Technologies Corporation、 GTH.O、 Paradigm Diagnostics、 Oxford Nanopore Technologies Ltd.、 Eurofins Scientific S.E.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、腫瘍NGS検出のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の腫瘍NGS検出市場：タイプ別、2018年-2023年、2024年-2029年 世界の腫瘍NGS検出市場：タイプ別市場シェア、2022年 ・医療機器、消耗品 世界の腫瘍NGS検出市場：用途別、2018年-2023年、2024年-2029年 世界の腫瘍NGS検出市場：用途別市場シェア、2022年 ・コンパニオン診断、早期癌スクリーニング、創薬、その他 世界の腫瘍NGS検出市場：地域・国別、2018年-2023年、2024年-2029年 世界の腫瘍NGS検出市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における腫瘍NGS検出のグローバル売上、2018年-2023年 ・主要企業における腫瘍NGS検出のグローバル売上シェア、2022年 ・主要企業における腫瘍NGS検出のグローバル販売量、2018年-2023年 ・主要企業における腫瘍NGS検出のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Agilent、 Thermo Fisher Scientific、 BGI Group、 Roche Foundation Medicine、 Sinopharm Group、 Fosunpharma、 Novogene、 Geneseeq、 AmoyDx、 Burning Rock Medicine、 Perkin Elmer、 Qiagen NV、 Partek、 Illumina Inc.、 Pacific Biosciences of California Inc.、 Life Technologies Corporation、 GTH.O、 Paradigm Diagnostics、 Oxford Nanopore Technologies Ltd.、 Eurofins Scientific S.E. ************************************************************* ・調査・分析レポートの概要 腫瘍NGS検出市場の定義 市場セグメント 世界の腫瘍NGS検出市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の腫瘍NGS検出市場規模 世界の腫瘍NGS検出市場規模：2022年 VS 2029年 世界の腫瘍NGS検出市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの腫瘍NGS検出の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の腫瘍NGS検出製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：医療機器、消耗品 腫瘍NGS検出のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：コンパニオン診断、早期癌スクリーニング、創薬、その他 腫瘍NGS検出の用途別グローバル売上・予測 ・地域別市場分析 地域別腫瘍NGS検出市場規模 2022年と2029年 地域別腫瘍NGS検出売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Agilent、 Thermo Fisher Scientific、 BGI Group、 Roche Foundation Medicine、 Sinopharm Group、 Fosunpharma、 Novogene、 Geneseeq、 AmoyDx、 Burning Rock Medicine、 Perkin Elmer、 Qiagen NV、 Partek、 Illumina Inc.、 Pacific Biosciences of California Inc.、 Life Technologies Corporation、 GTH.O、 Paradigm Diagnostics、 Oxford Nanopore Technologies Ltd.、 Eurofins Scientific S.E. ... |
This research report provides a comprehensive analysis of the Tumor NGS Detection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Tumor NGS Detection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Tumor NGS Detection, challenges faced by the industry, and potential opportunities for market players.
The global Tumor NGS Detection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Tumor NGS Detection market presents opportunities for various stakeholders, including Companion Diagnostics, Early Cancer Screening. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Tumor NGS Detection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Tumor NGS Detection market was valued at US$ 1730.7 million in 2022 and is projected to reach US$ 5043.3 million by 2029, at a CAGR of 16.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Tumor NGS Detection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Tumor NGS Detection market.
Market Overview: The report provides a comprehensive overview of the Tumor NGS Detection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Medical Equipment, Consumables), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Tumor NGS Detection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Tumor NGS Detection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Tumor NGS Detection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Tumor NGS Detection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Tumor NGS Detection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Tumor NGS Detection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Tumor NGS Detection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Tumor NGS Detection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Tumor NGS Detection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Medical Equipment
Consumables
Market segment by Application
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
Global Tumor NGS Detection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Agilent
Thermo Fisher Scientific
BGI Group
Roche Foundation Medicine
Sinopharm Group
Fosunpharma
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
Perkin Elmer
Qiagen NV
Partek
Illumina Inc.
Pacific Biosciences of California Inc.
Life Technologies Corporation
GTH.O
Paradigm Diagnostics
Oxford Nanopore Technologies Ltd.
Eurofins Scientific S.E.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tumor NGS Detection, market overview.
Chapter 2: Global Tumor NGS Detection market size in revenue.
Chapter 3: Detailed analysis of Tumor NGS Detection company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tumor NGS Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Tumor NGS Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor NGS Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor NGS Detection Overall Market Size
2.1 Global Tumor NGS Detection Market Size: 2022 VS 2029
2.2 Global Tumor NGS Detection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tumor NGS Detection Players in Global Market
3.2 Top Global Tumor NGS Detection Companies Ranked by Revenue
3.3 Global Tumor NGS Detection Revenue by Companies
3.4 Top 3 and Top 5 Tumor NGS Detection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tumor NGS Detection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor NGS Detection Players in Global Market
3.6.1 List of Global Tier 1 Tumor NGS Detection Companies
3.6.2 List of Global Tier 2 and Tier 3 Tumor NGS Detection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Tumor NGS Detection Market Size Markets, 2022 & 2029
4.1.2 Medical Equipment
4.1.3 Consumables
4.2 By Type – Global Tumor NGS Detection Revenue & Forecasts
4.2.1 By Type – Global Tumor NGS Detection Revenue, 2018-2023
4.2.2 By Type – Global Tumor NGS Detection Revenue, 2024-2029
4.2.3 By Type – Global Tumor NGS Detection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Tumor NGS Detection Market Size, 2022 & 2029
5.1.2 Companion Diagnostics
5.1.3 Early Cancer Screening
5.1.4 Drug Discovery
5.1.5 Other
5.2 By Application – Global Tumor NGS Detection Revenue & Forecasts
5.2.1 By Application – Global Tumor NGS Detection Revenue, 2018-2023
5.2.2 By Application – Global Tumor NGS Detection Revenue, 2024-2029
5.2.3 By Application – Global Tumor NGS Detection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Tumor NGS Detection Market Size, 2022 & 2029
6.2 By Region – Global Tumor NGS Detection Revenue & Forecasts
6.2.1 By Region – Global Tumor NGS Detection Revenue, 2018-2023
6.2.2 By Region – Global Tumor NGS Detection Revenue, 2024-2029
6.2.3 By Region – Global Tumor NGS Detection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Tumor NGS Detection Revenue, 2018-2029
6.3.2 US Tumor NGS Detection Market Size, 2018-2029
6.3.3 Canada Tumor NGS Detection Market Size, 2018-2029
6.3.4 Mexico Tumor NGS Detection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Tumor NGS Detection Revenue, 2018-2029
6.4.2 Germany Tumor NGS Detection Market Size, 2018-2029
6.4.3 France Tumor NGS Detection Market Size, 2018-2029
6.4.4 U.K. Tumor NGS Detection Market Size, 2018-2029
6.4.5 Italy Tumor NGS Detection Market Size, 2018-2029
6.4.6 Russia Tumor NGS Detection Market Size, 2018-2029
6.4.7 Nordic Countries Tumor NGS Detection Market Size, 2018-2029
6.4.8 Benelux Tumor NGS Detection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Tumor NGS Detection Revenue, 2018-2029
6.5.2 China Tumor NGS Detection Market Size, 2018-2029
6.5.3 Japan Tumor NGS Detection Market Size, 2018-2029
6.5.4 South Korea Tumor NGS Detection Market Size, 2018-2029
6.5.5 Southeast Asia Tumor NGS Detection Market Size, 2018-2029
6.5.6 India Tumor NGS Detection Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Tumor NGS Detection Revenue, 2018-2029
6.6.2 Brazil Tumor NGS Detection Market Size, 2018-2029
6.6.3 Argentina Tumor NGS Detection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Tumor NGS Detection Revenue, 2018-2029
6.7.2 Turkey Tumor NGS Detection Market Size, 2018-2029
6.7.3 Israel Tumor NGS Detection Market Size, 2018-2029
6.7.4 Saudi Arabia Tumor NGS Detection Market Size, 2018-2029
6.7.5 UAE Tumor NGS Detection Market Size, 2018-2029
7 Tumor NGS Detection Companies Profiles
7.1 Agilent
7.1.1 Agilent Company Summary
7.1.2 Agilent Business Overview
7.1.3 Agilent Tumor NGS Detection Major Product Offerings
7.1.4 Agilent Tumor NGS Detection Revenue in Global Market (2018-2023)
7.1.5 Agilent Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Tumor NGS Detection Major Product Offerings
7.2.4 Thermo Fisher Scientific Tumor NGS Detection Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 BGI Group
7.3.1 BGI Group Company Summary
7.3.2 BGI Group Business Overview
7.3.3 BGI Group Tumor NGS Detection Major Product Offerings
7.3.4 BGI Group Tumor NGS Detection Revenue in Global Market (2018-2023)
7.3.5 BGI Group Key News & Latest Developments
7.4 Roche Foundation Medicine
7.4.1 Roche Foundation Medicine Company Summary
7.4.2 Roche Foundation Medicine Business Overview
7.4.3 Roche Foundation Medicine Tumor NGS Detection Major Product Offerings
7.4.4 Roche Foundation Medicine Tumor NGS Detection Revenue in Global Market (2018-2023)
7.4.5 Roche Foundation Medicine Key News & Latest Developments
7.5 Sinopharm Group
7.5.1 Sinopharm Group Company Summary
7.5.2 Sinopharm Group Business Overview
7.5.3 Sinopharm Group Tumor NGS Detection Major Product Offerings
7.5.4 Sinopharm Group Tumor NGS Detection Revenue in Global Market (2018-2023)
7.5.5 Sinopharm Group Key News & Latest Developments
7.6 Fosunpharma
7.6.1 Fosunpharma Company Summary
7.6.2 Fosunpharma Business Overview
7.6.3 Fosunpharma Tumor NGS Detection Major Product Offerings
7.6.4 Fosunpharma Tumor NGS Detection Revenue in Global Market (2018-2023)
7.6.5 Fosunpharma Key News & Latest Developments
7.7 Novogene
7.7.1 Novogene Company Summary
7.7.2 Novogene Business Overview
7.7.3 Novogene Tumor NGS Detection Major Product Offerings
7.7.4 Novogene Tumor NGS Detection Revenue in Global Market (2018-2023)
7.7.5 Novogene Key News & Latest Developments
7.8 Geneseeq
7.8.1 Geneseeq Company Summary
7.8.2 Geneseeq Business Overview
7.8.3 Geneseeq Tumor NGS Detection Major Product Offerings
7.8.4 Geneseeq Tumor NGS Detection Revenue in Global Market (2018-2023)
7.8.5 Geneseeq Key News & Latest Developments
7.9 AmoyDx
7.9.1 AmoyDx Company Summary
7.9.2 AmoyDx Business Overview
7.9.3 AmoyDx Tumor NGS Detection Major Product Offerings
7.9.4 AmoyDx Tumor NGS Detection Revenue in Global Market (2018-2023)
7.9.5 AmoyDx Key News & Latest Developments
7.10 Burning Rock Medicine
7.10.1 Burning Rock Medicine Company Summary
7.10.2 Burning Rock Medicine Business Overview
7.10.3 Burning Rock Medicine Tumor NGS Detection Major Product Offerings
7.10.4 Burning Rock Medicine Tumor NGS Detection Revenue in Global Market (2018-2023)
7.10.5 Burning Rock Medicine Key News & Latest Developments
7.11 Perkin Elmer
7.11.1 Perkin Elmer Company Summary
7.11.2 Perkin Elmer Business Overview
7.11.3 Perkin Elmer Tumor NGS Detection Major Product Offerings
7.11.4 Perkin Elmer Tumor NGS Detection Revenue in Global Market (2018-2023)
7.11.5 Perkin Elmer Key News & Latest Developments
7.12 Qiagen NV
7.12.1 Qiagen NV Company Summary
7.12.2 Qiagen NV Business Overview
7.12.3 Qiagen NV Tumor NGS Detection Major Product Offerings
7.12.4 Qiagen NV Tumor NGS Detection Revenue in Global Market (2018-2023)
7.12.5 Qiagen NV Key News & Latest Developments
7.13 Partek
7.13.1 Partek Company Summary
7.13.2 Partek Business Overview
7.13.3 Partek Tumor NGS Detection Major Product Offerings
7.13.4 Partek Tumor NGS Detection Revenue in Global Market (2018-2023)
7.13.5 Partek Key News & Latest Developments
7.14 Illumina Inc.
7.14.1 Illumina Inc. Company Summary
7.14.2 Illumina Inc. Business Overview
7.14.3 Illumina Inc. Tumor NGS Detection Major Product Offerings
7.14.4 Illumina Inc. Tumor NGS Detection Revenue in Global Market (2018-2023)
7.14.5 Illumina Inc. Key News & Latest Developments
7.15 Pacific Biosciences of California Inc.
7.15.1 Pacific Biosciences of California Inc. Company Summary
7.15.2 Pacific Biosciences of California Inc. Business Overview
7.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Major Product Offerings
7.15.4 Pacific Biosciences of California Inc. Tumor NGS Detection Revenue in Global Market (2018-2023)
7.15.5 Pacific Biosciences of California Inc. Key News & Latest Developments
7.16 Life Technologies Corporation
7.16.1 Life Technologies Corporation Company Summary
7.16.2 Life Technologies Corporation Business Overview
7.16.3 Life Technologies Corporation Tumor NGS Detection Major Product Offerings
7.16.4 Life Technologies Corporation Tumor NGS Detection Revenue in Global Market (2018-2023)
7.16.5 Life Technologies Corporation Key News & Latest Developments
7.17 GTH.O
7.17.1 GTH.O Company Summary
7.17.2 GTH.O Business Overview
7.17.3 GTH.O Tumor NGS Detection Major Product Offerings
7.17.4 GTH.O Tumor NGS Detection Revenue in Global Market (2018-2023)
7.17.5 GTH.O Key News & Latest Developments
7.18 Paradigm Diagnostics
7.18.1 Paradigm Diagnostics Company Summary
7.18.2 Paradigm Diagnostics Business Overview
7.18.3 Paradigm Diagnostics Tumor NGS Detection Major Product Offerings
7.18.4 Paradigm Diagnostics Tumor NGS Detection Revenue in Global Market (2018-2023)
7.18.5 Paradigm Diagnostics Key News & Latest Developments
7.19 Oxford Nanopore Technologies Ltd.
7.19.1 Oxford Nanopore Technologies Ltd. Company Summary
7.19.2 Oxford Nanopore Technologies Ltd. Business Overview
7.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Major Product Offerings
7.19.4 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Revenue in Global Market (2018-2023)
7.19.5 Oxford Nanopore Technologies Ltd. Key News & Latest Developments
7.20 Eurofins Scientific S.E.
7.20.1 Eurofins Scientific S.E. Company Summary
7.20.2 Eurofins Scientific S.E. Business Overview
7.20.3 Eurofins Scientific S.E. Tumor NGS Detection Major Product Offerings
7.20.4 Eurofins Scientific S.E. Tumor NGS Detection Revenue in Global Market (2018-2023)
7.20.5 Eurofins Scientific S.E. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer